Material Agreements

Zoomcar Holdings, Inc. entered into ACM Letter Agreement with ACM Zoomcar Convert LLC valued at Judgment principal amount $6,000,000; cash payment $2,500,000; residual balance $3,500,000 to be sat (effective 2026-05-06).

“On May 6, 2026, Zoomcar Holdings, Inc. (the “Company”) entered into a letter agreement (the “ACM Letter Agreement”) with ACM Zoomcar Convert LLC (“ACM”), with respect to the previously disclosed judgment entered against the Company in favor of ACM in the principal amount of approximately $6,000,000 (together with interest and other amounts, the “ACM Judgment”).”

STORE CAPITAL LLC entered into Eleventh Amended and Restated Property Management and Servicing Agreement with KeyBank National Association (effective 2026-05-19).

“the Company also entered into the Eleventh Amended and Restated Property Management and Servicing Agreement, dated as of May 19, 2026 (the “ Property Management Agreement ”), among the Issuers, the Company, KeyBank National Association (“ KeyBank ”) and the Indenture Trustee”

STORE CAPITAL LLC entered into Series 2026-1 Supplement to the Indenture with Citibank, N.A. (effective 2026-05-19).

“are governed by the Series 2026-1 Supplement to the Indenture entered into by the Issuers and the Indenture Trustee on May 19, 2026 (the “ Indenture Supplement ”)”

STORE CAPITAL LLC entered into Twelfth Amended and Restated Master Indenture with Citibank, N.A. (effective 2026-05-19).

“The Notes were issued pursuant to the Twelfth Amended and Restated Master Indenture, dated as of May 19, 2026 (the “ Indenture ”), among the Issuers and Citibank, N.A. (the “ Indenture Trustee ”)”

STORE CAPITAL LLC entered into Note Purchase Agreement with initial purchasers party thereto valued at $589,000,000 aggregate principal amount (effective 2026-05-14).

“Notes in the aggregate principal amount of $567,000,000 were issued to qualified institutional investors (the “ Class A Notes ”). The remaining Notes, in the aggregate principal amount of $22,000,000, were issued to an affiliate of the Company (the “ Class B Notes ”). The Notes were issued to qualified institutional investors pursuant to a Note Purchase Agreement, entered into on May 14, 2026 (the “ Note Purchase Agreement ”), among the Company and the Issuers, and the initial purchasers party thereto”

Jaguar Health, Inc. entered into Second Streeterville Series Q Exchange Agreement with Streeterville Capital, LLC valued at $6,500,000 reduction in the outstanding balance (effective 2026-05-19).

“and (ii) a privately negotiated exchange agreement (the "Second Streeterville Series Q Exchange Agreement"; together with the Uptown Series Q Exchange Agreement and the First Streeterville Series Q Exchange Agreement, collectively, the "CVP Exchange Agreements") also with Streeterville, pursuant to which the Company issued 260 shares of Series Q Preferred Stock to Streeterville in exchange for an additional $6,500,000 reduction in the outstanding balance of the August 2022 Royalty Interest.”

Jaguar Health, Inc. entered into First Streeterville Series Q Exchange Agreement with Streeterville Capital, LLC valued at $3,700,000 reduction in the outstanding balance (effective 2026-05-19).

“On May 19, 2026, the Company entered into (i) a privately negotiated exchange agreement (the "First Streeterville Series Q Exchange Agreement") with Streeterville, pursuant to which the Company issued 148 shares of Series Q Preferred Stock to Streeterville in exchange for a $3,700,000 reduction in the outstanding balance of the August 2022 Royalty Interest”

Jaguar Health, Inc. entered into Uptown Series Q Exchange Agreement with Uptown Capital, LLC (f/k/a Irving Park Capital, LLC) valued at $12,500,000 reduction in the outstanding balance (effective 2026-05-19).

“On May 19, 2026, the Company entered into a privately negotiated exchange agreement (the "Uptown Series Q Exchange Agreement") with Uptown. Pursuant to the Uptown Series Q Exchange Agreement, the Company issued 500 shares of Series Q Perpetual Preferred Stock (the "Series Q Preferred Stock") to Uptown in exchange for a $12,500,000 reduction in the outstanding balance of the December 2020 Royalty Interest.”

Bank First Corp entered into Agreement and Plan of Merger with PSB Holdings, Inc. (effective 2026-05-19).

“On May 19, 2026, Bank First Corporation, a Wisconsin corporation (“BFC”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with PSB Holdings, Inc., a Wisconsin corporation (“PSB”), whereby PSB will be merged with and into BFC (the “Merger”).”

GeoVax Labs, Inc. entered into Placement Agency Agreement with A.G.P./Alliance Global Partners (the “Placement Agent”) (effective 2026-05-18).

“A.G.P./Alliance Global Partners (the “Placement Agent”) acted as the exclusive placement agent in connection with the Offering under a Placement Agency Agreement, dated as of May 18, 2026 (the “Placement Agency Agreement”) between the Company and the Placement Agent.”

GeoVax Labs, Inc. entered into Purchase Agreement with the purchasers party thereto (effective 2026-05-18).

“On May 18, 2026, GeoVax Labs, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers party thereto, pursuant to which the Company agreed to issue and sell, in an unregistered private placement (the “Offering”), (i) pre-funded warrants”

Aether Holdings, Inc. entered into Purchase Agreement with Streeterville Capital, LLC valued at $3,240,000.00 (effective 2026-05-13).

“On May 13, 2026, Aether Holdings, Inc., a Delaware corporation (the “Company”), entered into a note purchase agreement (the “Purchase Agreement”) with Streeterville Capital, LLC, a Utah limited liability company (the “Lender”), pursuant to which the Company issued and sold to the Lender a secured promissory note in the original principal amount of $3,240,000.00 (the “Note”).”

HF Sinclair Corp entered into Stock Purchase Agreement with REH Advisors Inc. (the "Selling Stockholder" or "REH") valued at aggregate purchase price of $100 million (effective 2026-05-18).

“HF Sinclair Corporation (the “Company”) entered into a Stock Purchase Agreement, dated May 18, 2026 (the “Stock Purchase Agreement”), with REH Advisors Inc. (the “Selling Stockholder” or “REH”) (now the parent company of REH Company, LLC (formerly known as The Sinclair Companies)), pursuant to which the Company agreed to repurchase from the Selling Stockholder 1,455,180 shares of the Company’s outstanding common stock, par value $0.01 per share (the “Common Stock”), in a privately negotiated transaction. The price per share to be paid by the Company under the Stock Purchase Agreement is $68.72 per share resulting in an aggregate purchase price of $100 million.”

Eton Pharmaceuticals, Inc. entered into Supply and Distribution Agreement for IMPAVIDO® with affiliate of Knight Therapeutics, Inc. valued at $4.25 million fixed fees plus up to $4.0 million sales milestones and 55%/50% net sales share (effective 2026-05-18).

“On May 18, 2026, Eton Pharmaceuticals, Inc. (“Eton” or the “Company”) entered into a supply and distribution agreement for the United States commercialization rights to IMPAVIDO® (miltefosine) oral capsules with an affiliate of Knight Therapeutics, Inc. (“Supplier”).”

GoPro, Inc. entered into Lease with PenLark, L.P. valued at approximately $87,500 per month (effective 2026-04-16).

“On April 16, 2026, GoPro, Inc. (the “Company”), entered into a lease agreement (the “Lease”) with PenLark, L.P. (the “Landlord”), pursuant to which the Company will lease approximately 25,000 square feet of space located at 2855 Campus Drive, San Mateo, CA 94403 (the “Premises”).”

Sabre Corp entered into New Exchangeable Notes Indenture with U.S. Bank Trust Company, National Association valued at $150.0 million aggregate principal amount of 7.00% Exchangeable Senior Notes due 2031 (effective 2026-05-18).

“On May 18, 2026, Sabre GLBL Inc. (“Sabre GLBL”), a wholly-owned subsidiary of Sabre Corporation (“Sabre”), issued $150.0 million aggregate principal amount of 7.00% Exchangeable Senior Notes due 2031 (the “New Exchangeable Notes”) under an indenture, dated May 18, 2026 (the “New Exchangeable Notes Indenture”), among Sabre GLBL, as issuer, and Sabre and Sabre Holdings Corporation (“Sabre Holdings”), as guarantors, and U.S. Bank Trust Company, National Association, as trustee.”

HUMANA INC entered into trust expense reimbursement agreements with Horseshoe Funding Trust I, Horseshoe Funding Trust II (effective 2026-05-15).

“The Company also entered into separate trust expense reimbursement agreements with each Trust. An Issuance Right will be exercised automatically in full upon certain payment defaults under the applicable Facility Agreement or trust expense reimbursement agreement, or upon certain bankruptcy events involving the Company.”

HUMANA INC entered into Facility Agreements with Horseshoe Funding Trust I, Horseshoe Funding Trust II, The Bank of New York Mellon Trust Company, N.A., as trustee valued at up to $750,000,000 aggregate principal amount of the applicable Senior Notes (effective 2026-05-15).

“On the Closing Date, the Company also entered into separate facility agreements (each, a “Facility Agreement”) with each Trust and The Bank of New York Mellon Trust Company, N.A., as trustee for the Senior Notes (the “Trustee”). Under the Facility Agreements, each Trust granted the Company the right to require such Trust to purchase, on one or more occasions, up to $750,000,000 aggregate principal amount of the applicable Senior Notes”

HUMANA INC entered into Purchase Agreements with Goldman Sachs & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc., Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC, as representatives of the several initial purchasers valued at $750,000,000 per Trust (effective 2026-05-05).

“On May 15, 2026 (the “Closing Date”), pursuant to separate Purchase Agreements, dated May 5, 2026, among Humana Inc. (the “Company”), Goldman Sachs & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc., Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC, as representatives of the several initial purchasers, and Horseshoe Funding Trust I (the “2036 Trust”) and Horseshoe Funding Trust II (the “2055 Trust” and, together with the 2036 Trust, the “Trusts”), the 2036 Trust and the 2055 Trust each completed the issuance and sale of 750,000 Pre-Capitalized Trust Securities (the “2036 P-Caps” and the “2055 P-Caps,” respectively, and together, the “P-Caps”) for an aggregate purchase price of $750,000,000 per Trust”

Healthcare Realty Trust Inc entered into Term Loan Agreement with Wells Fargo Bank, National Association, as Administrative Agent; Wells Fargo Securities, LLC, BofA Securities, Inc., Fifth Third Bank, National Association, JPMorgan Chase Bank, N.A., PNC Capital Markets LLC, Regions Capital Markets, a division of Regions Bank, Truist Securities, Inc. and U.S. Bank valued at $400.0 million (effective 2026-05-15).

“On May 15, 2026, (the “Closing Date”), Healthcare Realty Trust Incorporated (the “Company”) and its operating partnership, Healthcare Realty Holdings, L.P. (the “Borrower”), entered into a Term Loan Agreement (the “Term Loan Agreement"), with Wells Fargo Bank, National Association, as Administrative Agent; Wells Fargo Securities, LLC, BofA Securities, Inc., Fifth Third Bank, National Association, JPMorgan Chase Bank, N.A., PNC Capital Markets LLC, Regions Capital Markets, a division of Regions Bank, Truist Securities, Inc. and U.S. Bank National Association, as Joint Lead Arrangers and Joint Book Runners; Bank of America, N.A., Fifth Third Bank, National Association, JPMorgan Chase Bank, N.A., PNC Bank, National Association, Regions Bank, Truist Bank and U.S. Bank National Association, as Co-Syndication Agents; and the other lenders named therein.”

Blackstone Digital Infrastructure Trust Inc. entered into Credit Facility with Citibank, N.A., as administrative agent, and the lenders from time to time party thereto valued at $1.0 billion (effective 2026-05-15).

“On May 15, 2026, the Operating Partnership, which is referred to in this section as the “Borrower,” entered into a $1.0 billion senior secured revolving credit facility with Citibank, N.A., as administrative agent, and the lenders from time to time party thereto (the “Credit Facility”).”

MSP Recovery, Inc. entered into Advance Letter with VRM MSP Recovery Partners, LLC valued at One-time advance of recovery proceeds of $0.1 million (effective 2026-05-15).

“On May 15, 2026, the Company entered into a letter agreement (the “Advance Letter”) with VRM MSP Recovery Partners, LLC (“VRM”), pursuant to which VRM agreed to make available a one-time advance of recovery proceeds of $0.1 million to be used primarily to support the Company’s accounts payables.”

MSP Recovery, Inc. entered into Hazel Letter Agreement with Hazel Partners Holdings LLC valued at $0.1 million one-time advance (effective 2026-05-15).

“On May 15, 2026, MSP Recovery, Inc. (the “Company”), through its subsidiaries, entered into a letter agreement with Hazel Partners Holdings LLC (“Hazel”), in its capacity as administrative agent and lender under the Company’s existing working capital credit facility (the “Hazel Letter Agreement”) to provide $0.1 million to be used primarily for operating expenses.”

HPS Corporate Lending Fund entered into Registration Rights Agreement with Wells Fargo Securities, LLC, BNP Paribas Securities Corp., Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, SMBC Nikko Securities America, Inc. and Truist Securities, Inc. (effective 2026-05-19).

“the Fund entered into a Registration Rights Agreement, dated as of May 19, 2026, with Wells Fargo Securities, LLC, BNP Paribas Securities Corp., Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, SMBC Nikko Securities America, Inc. and Truist Securities, Inc. as the representatives of the initial purchasers of the Notes (the “ Registration Rights Agreement ”)”

HPS Corporate Lending Fund entered into Eleventh Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $600,000,000 (effective 2026-05-19).

“On May 19, 2026, HPS Corporate Lending Fund (the “ Fund ”) and U.S. Bank Trust Company, National Association (the “ Trustee ”) entered into an Eleventh Supplemental Indenture (the “ Eleventh Supplemental Indenture ”) relating to the Fund’s issuance of $ 600,000,000 in aggregate principal amount of its 6.300% notes due 2031 (the “ Notes ”)”

PATTERSON UTI ENERGY INC entered into Third Supplemental Indenture to Base Indenture, dated as of November 15, 2019 with U.S. Bank Trust Company, National Association valued at $500 million aggregate principal amount of 6.050% Senior Notes due 2036 (effective 2026-05-19).

“On May 19, 2026, Patterson-UTI Energy, Inc. (the “Company”) completed its previously announced offering (the “Offering”) of $500 million aggregate principal amount of the Company’s 6.050% Senior Notes due 2036 (the “Notes”).”

Sunshine Biopharma Inc. entered into Placement Agent Agreement with Aegis Capital Corp. valued at approximately $6 million (effective 2026-05-18).

“On May 18, 2026, Sunshine Biopharma Inc. (the “Company”) entered into a placement agent agreement (the “Placement Agent Agreement”) with Aegis Capital Corp. (the “Placement Agent”), in connection with a best efforts public offering”

Bio Essence Corp amended Asset Purchase Agreement with Zhituo Software Co., Limited valued at shares assigned to three individual stakeholders (effective 2026-05-09).

“On May 9, 2026, Zhituo’s three principals, Dangwei Zhu, Jiahui Zhang, and Xiaoquiang Cai, executed assignment agreements whereby each of the principals would receive a portion of the shares reserve for Zhituo pursuant to the APA.”

Bio Essence Corp entered into Asset Purchase Agreement with Zhituo Software Co., Limited valued at common stock valued at $3,500,000 (effective 2026-04-20).

“On April 20, 2026, Bio Essence Corp., a California corporation (“Company”) entered into a Asset Purchase Agreement (“APA”) with Zhituo Software Co., Limited, a company incorporated under the laws of Hong Kong (“Zhituo”).”

Nexalin Technology, Inc. entered into Collaboration Agreement with GreenLight Ventures LLC valued at 10,000 per month (effective 2026-05-14).

“On May 14, 2026, the Company entered into a Collaboration Agreement (the “Collaboration Agreement”) with GLV to support the development, compliance and commercialization of the Company’s cranial electrotherapy stimulation technologies and related products using certain licensed software associated with GLV’s digital technology platforms.”

Nexalin Technology, Inc. entered into Stock Purchase Agreement with GreenLight Ventures LLC valued at 1,300,000 (effective 2026-05-14).

“On May 14, 2026, Nexalin Technology, Inc. (the “Company”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) with GreenLight Ventures LLC, a North Carolina limited liability company (“GLV”).”

MOBIX LABS, INC terminated Original Note with Leviston Resources, LLC valued at $4 million (effective 2026-05-18).

“On May 18, 2026, the Company satisfied in full the entire $4 million of outstanding principal under the Original Note, together with all accrued interest thereon, through the conversion of such amounts into shares of Common Stock.”

MOBIX LABS, INC amended First Amendment with Leviston Resources, LLC valued at $4 million (effective 2026-05-13).

“On May 13, 2026, Mobix Labs, Inc. (the “Company”) entered into a first amendment to the securities purchase agreement and senior secured convertible promissory note (the “First Amendment”), with Leviston Resources, LLC (“Leviston”), amending the senior secured convertible note originally issued on March 31, 2026 (the “Original Note”) to increase the principal amount from $3 million to $4 million in exchange for an additional cash advance of $833,333 to the Company.”

InMed Pharmaceuticals Inc. entered into Agreement and Plan of Merger and Reorganization with Mentari Therapeutics, Inc. valued at equity value of $125,000,000 (effective 2026-05-19).

“ub, the “ Merger Subs ”), and Mentari Therapeutics, Inc., a Delaware corporation (“ Mentari ”), entered into an Agreement and Plan of Merger and Reorganization (the “ Merger Agreement ”), pursuant to which, among other matters”

Mister Car Wash, Inc. terminated Amended and Restated Stockholders Agreement with Green Equity Investors VI, L.P., Green Equity Investors Side VI, L.P., LGP Associates VI-A LLC and LGP Associates VI-B LLC (effective 2026-05-19).

“In connection with the consummation of the Merger, Green Equity Investors VI, L.P., Green Equity Investors Side VI, L.P., LGP Associates VI-A LLC and LGP Associates VI-B LLC (collectively, the “ Principal Stockholders ”), all of which are affiliates and/or affiliated funds of LGP, terminated that certain Amended and Restated Stockholders Agreement, dated June 29, 2021, by and among the Company and certain of its stockholders.”

Mister Car Wash, Inc. amended Amendment with Bank of America, N.A., Jefferies Finance LLC, the lenders from time to time party thereto and the other parties party thereto valued at $900 million (effective 2026-05-19).

“Borrower entered into Amendment No. 7 (the “ Amendment ”) to its existing Amended and Restated First Lien Credit Agreement, dated as of May 14, 2019, by and among Borrower, Hotshine IntermediateCo, Inc., the other guarantors party thereto, Bank of America, N.A., as the resigning administrative agent and collateral agent, Jefferies Finance LLC, as the successor administrative agent and collateral agent, the lenders from time to time party thereto and the other parties party thereto (as amended prior to the effectiveness of the Amendment, the “ Company Credit Agreement ”), pursuant to which certain financial institutions provided Borrower with, among other things, a $900 million senior secured first lien incremental term loan facility to fund the aggregate consideration owed to the Company’s stockholders in connection with the Merger and pay transaction fees and expenses.”

Exyn Technologies, Inc. entered into Warrant Agency Agreement with Equiniti Trust Company, LLC valued at Warrant agency services for Warrants issued in IPO; exercise price $9.69 per share; 5-year term (effective 2026-05-14).

“Also on May 14, 2026, the Company entered into a warrant agency agreement (the “ Warrant Agency Agreement ”) with Equiniti Trust Company, LLC (“ Equiniti ”), as warrant agent, in connection with the issuance, registration, transfer, exchange and exercise of the Warrants issued in the IPO, a form of which was previously filed as an exhibit to the Company’s Registration Statement filed with the Commission.”

Exyn Technologies, Inc. entered into Underwriting Agreement with Lucid Capital Markets, LLC valued at 2,500,000 Units at $7.13 per Unit; underwriter discount $0.62 per Unit (effective 2026-05-14).

“On May 14, 2026, Exyn Technologies, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Lucid Capital Markets, LLC (“ Lucid ”), as representative of the underwriters named therein (the “ Underwriters ”), relating to the Company’s previously announced initial public offering (the “ IPO ”) of 2,500,000 units (the “ Units ”), with each Unit consisting of one share of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”), and one warrant to purchase one share of Common Stock (each, a “ Warrant ”), a form of which was previously filed as an exhibit to the Company’s registration statement on Form S-1, File No. 333-294453, as amended (the “ Registration Statement ”), filed with the U.S. Securities and Exchange Commission (the “ Commission ”).”

Kimbell Royalty Partners, LP entered into Purchase and Sale Agreement with Mesa Visa Royalties, LLC, Mesa Royalties III Holdings, LLC, Mesa Land Company, LLC valued at approximately $44 million in cash (effective 2026-05-18).

“On May 18, 2026, Kimbell Royalty Partners, LP, a Delaware limited partnership (“Kimbell”), and Kimbell Royalty Operating, LLC, a Delaware limited liability company (“OpCo” and, together with Kimbell, the “Buyer Parties”), entered into a Purchase and Sale Agreement (the “Purchase Agreement”) with Mesa Visa Royalties, LLC, a Delaware limited liability company, (“Mesa Royalties”), Mesa Royalties III Holdings, LLC, a Delaware limited liability company (“Mesa Holdings”), Mesa Land Company, LLC, a Delaware limited liability company (“Mesa Land”, and, together with Mesa Royalties and Mesa Holdings, collectively “Sellers”) to acquire certain rights, title and interests in and to certain mineral interests”

Diversified Energy Co entered into Indenture with UMB Bank, N.A., as Indenture Trustee valued at $850 million (effective 2026-05-13).

“The ABS XII Notes were issued under a Base Indenture (the “Base Indenture”) and related Series 2026-1 Supplement (the “Supplement” and together with the Base Indenture, the “Indenture”) each dated May 13, 2026”

PITNEY BOWES INC /DE/ amended Credit Agreement with Bank of America, N.A. valued at Amended Credit Agreement with interest coverage ratio not less than 2.00 to 1.00, secured net levera (effective 2026-05-18).

“On May 18, 2026 (the “ Amendment Effective Date ”), Pitney Bowes Inc. (the “ Company ”), and certain other subsidiaries of the Company, entered into an amendment (the “ Amendment ”) to its Credit Agreement, dated as of February 7, 2025 (as amended prior to the date hereof and as further amended by the Amendment, the “ Credit Agreement ”), among the Company, the Loan Parties party thereto, the Lenders and Issuing Banks party thereto and Bank of America, N.A., as the administrative agent.”

RMX INDUSTRIES, INC. entered into Subscription Agreement with certain accredited investors valued at $1,360,000 (effective 2026-04-17).

“On April 17, 2026, the Company conducted a closing of its ongoing private placement offering (the “Offering”) and entered into a subscription agreement (the “Subscription Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company agreed to issue and sell 54.4 units (the “Units”), with each Unit consisting of (i) an unsecured 18% promissory note (the “Note”) and (ii) a five year warrant to purchase shares of Class A Common Stock with an exercise price of $0.50 per share (the “Warrants”).”

RMX INDUSTRIES, INC. entered into IP Purchase Agreement with Apollo Group Enterprises, LLC valued at 1,500,000 shares of Class A Common Stock (effective 2026-05-08).

“On May 8, 2026, RMX Industries, Inc. (the “Company”) entered into an intellectual property purchase agreement (the “IP Purchase Agreement”) with Apollo Group Enterprises, LLC (“Apollo”), pursuant to which the Company will acquire all of Apollo’s right, title and interest in and to certain intellectual property assets described therein relating to software platforms (the “IP Assets”) in consideration for issuing Apollo 1,500,000 shares”

AIM ImmunoTech Inc. amended Amendment #2 to Promissory Note with Streeterville Capital, LLC valued at extension fee in the amount of $10,000.00 (effective 2026-05-18).

“On May 18, 2026, the Company and the Lender entered into Amendment #2 to Promissory Note (the “Amendment”), which amended the Note and further extended the maturity date of the Note until June 30, 2027. Pursuant to the Amendment, the Company agreed to pay the Lender an extension fee in the amount of $10,000.00 (the “Extension Fee”), which Extension Fee was added to the outstanding balance of the Note.”

InMed Pharmaceuticals Inc. amended Armistice Preferred Investment Option Amending Agreement with Armistice Capital Master Fund Ltd. (effective 2026-05-18).

“On May 18, 2026, the Company entered into a preferred investment option amending agreement (the "Armistice Preferred Investment Option Amending Agreement") with Armistice to amend the Armistice Exercise Price contained in the Armistice Preferred Investment Options from $16.60 to $0.80.”

SONIDA SENIOR LIVING, INC. entered into Distribution Agreement with RBC Capital Markets, LLC, BMO Capital Markets Corp., Citigroup Global Markets Inc., Citizens JMP Securities, LLC, Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Morgan Stanley & Co. LLC, R. Seelaus & Co., LLC and Wells Fargo Securities, LLC valued at $250,000,000 (effective 2026-05-18).

“On May 18, 2026, Sonida Senior Living, Inc. (the “Company” ) entered into an equity distribution agreement (the “ Distribution Agreement ”)”

Ideal Power Inc. entered into Securities Purchase Agreement with certain investors valued at approximately $30.0 million (effective 2026-05-14).

“On May 14, 2026, Ideal Power Inc. (the “ Company ”) entered into a securities purchase agreement (the “ Securities Purchase Agreement ”) with certain investors (the “ Investors ”), relating to the offering of 3,220,961 shares of the Company’s common stock, par value $0.001 per share (“ Common Stock ”), and pre-funded warrants (the “ Pre-Funded Warrants ”) to purchase up to 2,070,044 shares of Common Stock (the “ Offering ”).”

ImmunityBio, Inc. entered into Exclusive Development and Supply Agreement with Japan BCG Laboratory valued at No payment due prior to FDA approval; minimum 2 batches per year after approval (effective 2026-05-14).

“On May 14, 2026, ImmunityBio, Inc., a Delaware corporation (“ImmunityBio” or the “Company”), entered into an exclusive development and supply agreement (the “Agreement”) with Japan BCG Laboratory, a Japanese corporation (“JBL”).”

GSR V Acquisition Corp. entered into Investment Management Trust Agreement with Odyssey Transfer and Trust Company (effective 2026-05-13).

“an Investment Management Trust Agreement, dated May 13, 2026, between the Company and Odyssey Transfer and Trust Company, as trustee, attached hereto as Exhibit 10.2 and incorporated herein by reference;”

GSR V Acquisition Corp. entered into Rights Agreement with Odyssey Transfer and Trust Company (effective 2026-05-13).

“a Rights Agreement, dated May 13, 2026, between the Company and Odyssey Transfer and Trust Company, as Rights agent, attached hereto as Exhibit 4.1 and incorporated by reference herein”